ANDREW WHITE: Open Payments
NPI 1043791247 · SAFFORD, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 29 payments from 12 companies in 2025. Trend: 2023 $422 · 2024 $448 · 2025 $674
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $174 |
| Abbott Laboratories | 3 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Novo Nordisk Inc | 3 | $59 |
| Exact Sciences Corporation | 3 | $53 |
| Gilead Sciences, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Renalytix AI, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: AIRSUPRA, FREESTYLE LIBRE 3, JARDIANCE, Kerendia, Cologuard Collection Kit, Ozempic, Epclusa, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
